ALICO, INC (ALCO)
A land management company involved in various agribusiness activities in central and southwest Florida, Alico, Inc. manages successful citrus fruit production, sod, sugarcane, cattle ranching and forestry operations. In addition, the company leases land for farming, cattle grazing, recreation and oil exploration.
Applied Minerals (AMNL:OB)
Rubenstein Investor Relations introduced Applied Minerals – a leading global producer of the mineral Halloysite – to a select audience of institutions, investment bankers, special situation funds and retail broker dealers that invest in ore exploration and mining. Halloysite is aluminosilicate clay that forms naturally occurring nanotubes, which are used as carriers of active ingredients in paint, coatings and building materials, agricultural applications and high-performance fillers in plastic composites.
Advanced Battery Technologies, Inc. (ABAT)
Advanced Battery Technologies, Inc., founded in September 2002, develops, manufactures and distributes rechargeable Polymer Lithium-Ion (PLI) batteries, used in electric automobiles, motorcycles, mine-use lamps, notebook computers, walkie-talkies and other electronic devices.
ABAT’s batteries combine high-energy chemistry with state-of-the-art polymer technology to overcome many of the shortcomings associated with other types of rechargeable batteries.
In early 2009, ABAT acquired Wuxi Angell Autocycle Co. Ltd., an electric-vehicle business with a New York office and executive office and manufacturing facilities in China, renaming it Wuxi Zhongqiang Autocycle Co., Ltd. (“Wuxi ZQ”).
Rubenstein Investor Relations (RIR) continues to build exposure for ABAT within the institutional and retail investment community, preparing presentations for major industry conferences including Rodman & Renshaw and Piper Jaffray, as well as institutional one-on-one meetings held throughout the country. RIR’s Wall Street professionals also initiate daily-investor calls and routinely disseminate updated collateral to target brokers.
Cardiogenics is the first company to manufacture a highly portable blood diagnostic machine to quickly determine if a patient is having a heart attack, with test results having the same accuracy and specificity as larger lab-based systems, but in less than one-tenth the time (15 minutes vs. 2.8 hours). The portable analyzer, made for widespread use in doctor’s offices, emergency rooms and ambulances, is easy to operate – just a few drops of blood, no operator training, and walk-away operation.
Rubenstein Investor Relations executed institutional, investment-banking, and retail campaigns for Cardiogenics, including numerous roadshows and an ongoing conference-call schedule. The results were an increase in institutional ownership, greater company valuation and a broader distribution of stock. These results provided strong support in the stock when additional financing was obtained.
Since the onset of the campaign, the company has experienced a rise in valuation from $0.27 to as high as $1.30. The company currently trades over $1.00 with a broader shareholder base and a reduction in price volatility. Currently, banking interest is rising and funding opportunities are being explored.